Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Kappos, L' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 59 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kristoferitsch, W; Seeldrayers, P; Kyriallis, K; Brochet, B; Confavreux, C; Clanet, M; Cesaro, P; Defer, G; Edan, G; Lyon-Caen, O; Pelletier, J; Rumbach, L; Roullet, E; Vermersch, P; Dengler, R; Zschenderlein, R; Storch-Hagenlocher, B; Sailer, M; Hohlfeld, R; Kunze, KP; Heesen, C; Bamborschke, P; Grunwald, F; Hartung, HP; Rieckmann, P; DeKeyser, J; Montalban, X; Fernandez, U; Arbizu, T; Sandberg, M; Kappos, L; Bates, D; Campbell, MJ; Capildeo, R; Compston, A; McLellan, DL; Wroe, S; Young, C; Clanet, M; Hartung, HP; Hohlfeld, R; Kappos, L; Radue, EW; Rieckmann, P; Sandberg, M; Polman, C; Kesselring, J; Thompson, A; Wekerle, H; Whitehead, J; Bains, H; Butler, E; Kooijmans-Coutinho, M; McAllister, A; Simonian, N; White, K; Anderson, D; Liddiard, S; Keane, R
      Double-blind randomized multicenter dose-comparison study of interferon-beta-1a (AVONEX): rationale, design and baseline data

      MULTIPLE SCLEROSIS
    2. Kappos, L; Comi, G; Panitch, H; Oger, J; Antel, J; Conlon, P; Steinman, L
      Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. (vol 6, pg 1176, 2000)

      NATURE MEDICINE
    3. Constantinescu, CS; Grygar, C; Kappos, L; Leppert, D
      Interleukin 15 stimulates production of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by human peripheral blood mononuclear cells

      CYTOKINE
    4. Leppert, D; Lindberg, RLP; Kappos, L; Leib, SL
      Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis

      BRAIN RESEARCH REVIEWS
    5. Kappos, L; Polman, C; Pozzilli, C; Thompson, A; Beckmann, K; Dahlke, F
      Final analysis of the European multicenter trial on IFN beta-1b in secondary-progressive MS

      NEUROLOGY
    6. Freeman, JA; Thompson, AJ; Fitzpatrick, R; Hutchinson, M; Miltenburger, C; Beckmann, K; Dahlke, F; Kappos, L; Polman, C; Pozzilli, C
      Interferon-beta 1b in the treatment of secondary progressive MS - Impact on quality of life

      NEUROLOGY
    7. Francis, G; Hughes, R; King, J; Mitchell, P; Joubert, J; McLeod, J; Parker, G; Pollard, J; Sindic, CJM; Duprez, T; Medaer, R; Broeckx, J; Vanroose, E; Carton, H; Wilms, G; Rice, G; Ebers, G; Lee, DH; Freedman, M; Nelson, R; Rabinovitch, H; Christie, S; Avruch, L; Oger, J; Paty, DW; Li, D; Wikstrom, J; Salonen, OLM; Panelius, M; Eralinna, J; Sonninen, P; Rieckmann, P; Hahn, D; Flachenecker, P; Hartung, HP; Uitdehaag, B; Bertelsmann, FW; Barkhof, F; Hommes, OR; Jongen, PJH; Van Doorn, PA; Tanghe, HLG; Sandberg-Wollheim, M; Larsson, EM; Lonntoft, M; Sallerfors, S; Kappos, L; Lienert, C; Radu, EW; Chofflon, M; Roth, S; Castillo, V; Schwieger, AF; Hughes, RAC; Clews, AM; Bingham, JB; Barnes, D; Clifton, AG; Stoy, N; Bates, D; Coulthard, A; Blumhardt, LD; Evans, SM; Jaspan, T; Palace, J; Newsom-Davis, JM; Byrne, JV; Quaghebeur, G; Li, DKB; Paty, DW; Zhao, GJ; Riddehough, A; Rhodes, B
      PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS

      NEUROLOGY
    8. Buttner, U; Chofflon, M; Hess, K; Kappos, L; Kesselring, J; Ludin, HP; Schluep, M; Vaney, C; Baumhackl, U; Berger, T; Deisenhammer, F; Freimuller, M; Hartung, HP; Kollegger, H; Kristoferitsch, W; Lassmann, H; Markut, H; Vass, K; Altenkirch, H; Boese, J; Gass, A; Gehlen, W; Goebels, N; Haas, J; Haferkamp, G; Heidenreich, F; Heitmann, R; Hemmer, B; Hohlfeld, R; Janzen, RWC; Jugelt, E; Kolmel, W; Konig, N; Kowitzsch, K; Manegold, U; Melms, A; Mertin, J; Petereit, HF; Pette, M; Pohlau, D; Poser, S; Sailer, M; Schmidt, S; Schock, G; Schulz, M; Seidel, D; Stangel, M; Stark, E; Stoll, G; Weinrich, W; Wietholter, H; Zettl, UK; Zipp, F; Zschenderlein, R; Bayas, A; Chan, A; Flachenecker, P; Gold, R; Grauer, O; Jung, S; Kallmann, B; Leussink, V; Maurer, M; Rieckmann, P; Toyka, KV; Weilbach, FX
      Escalating immunomodulatory therapy of multiple sclerosis - 1. Supplement

      NERVENARZT
    9. Lindberg, RLP; De Groot, CJA; Montagne, L; Freitag, P; van der Valk, P; Kappos, L; Leppert, D
      The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis

      BRAIN
    10. Barkhof, F; van Waesberghe, JHTM; Filippi, M; Yousry, T; Miller, DH; Hahn, D; Thompson, AJ; Kappos, L; Brex, P; Pozzilli, C; Polman, CH
      T-1 hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment

      BRAIN
    11. Miller, DH; Thompson, AJ; Kappos, L
      MRI and assessment of treatment in multiple sclerosis

      BRAIN
    12. Fuhr, P; Borggrefe-Chappuis, A; Schindler, C; Kappos, L
      Visual and motor evoked potentials in the course of multiple sclerosis

      BRAIN
    13. Boureau, F; Kappos, L; Schoenen, J; Esperanca, P; Ashford, E
      A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    14. Constantinescu, CS; Freitag, P; Kappos, L
      Increase in serum levels of uric acid, an endogenous antioxidant, under treatment with glatiramer acetate for multiple sclerosis

      MULTIPLE SCLEROSIS
    15. Kappos, L; Comi, G; Panitch, H; Oger, J; Antel, J; Conlon, P; Steinman, L
      Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial

      NATURE MEDICINE
    16. Shamshiev, A; Donda, A; Prigozy, TI; Mori, L; Chigorno, V; Benedict, CA; Kappos, L; Sonnino, S; Kronenberg, M; De Libero, G
      The alpha beta T cell response to self-glycolipids shows a novel mechanismof CD1b loading and a requirement for complex oligosaccharides

      IMMUNITY
    17. Haselhorst, R; Kappos, L; Bilecen, D; Scheffler, K; Mori, D; Radu, EW; Seelig, J
      Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: Application of an extended blood-brain barrier leakage correction

      JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING
    18. Comi, G; Kappos, L; Clanet, M; Ebers, G; Fassas, A; Fazekas, F; Filippi, M; Hartung, HP; Hertenstein, B; Karussis, D; Martino, G; Tyndall, A; van der Meche, FGA
      Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation

      JOURNAL OF NEUROLOGY
    19. Molyneux, PD; Miller, DH; Filippi, M; Yousry, T; Kappos, L; Gasperini, C; Ader, HJ; Barkhof, F
      The use of magnetic resonance imaging in multiple sclerosis treatment trials: power calculations for annual lesion lend measurement

      JOURNAL OF NEUROLOGY
    20. Mader, I; Roser, W; Kappos, L; Hagberg, G; Seelig, J; Radue, EW; Steinbrich, W
      Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: Absolute metabolic values over 2 years during a clinical pharmacological study

      AMERICAN JOURNAL OF NEURORADIOLOGY
    21. Strub, M; Fuhr, P; Kappos, L
      Late manifestation of radiation injury to plexus brachialis and plexus lumbosacralis

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    22. Radziwill, AJ; Kappos, L; Battegay, M; Steck, AJ
      Neurological complications of HIV infection

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    23. Wiendl, H; Neuhaus, O; Kappos, L; Hohlfeld, R
      Multiple sclerosis: a current overview of failed and interrupted treatmenttrials

      NERVENARZT
    24. Grossman, RI; Kappos, L; Wolinsky, JS
      The contribution of magnetic resonance imaging in the differential diagnosis of the damage of the cerebral hemispheres

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    25. Molyneux, PD; Kappos, L; Polman, C; Pozzilli, C; Barkhof, F; Filippi, M; Yousry, T; Hahn, D; Wagner, K; Ghazi, M; Beckmann, K; Dahlke, F; Losseff, N; Barker, GJ; Thompson, AJ; Miller, DH
      The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis

      BRAIN
    26. Lienert, C; Lechner-Scott, J; Schott, D; Constantinescu, C; Kappos, L
      Use of composite scares in the quantification of deterioration in multiplesclerosis

      MULTIPLE SCLEROSIS
    27. Gass, A; Radu, EW; Filippi, M; Kappos, L
      MRI follow-up examinations in multiple sclerosis: Guidelines for quality assurance.

      ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
    28. Huber, S; Kappos, L; Fuhr, P; Wetzel, S; Steck, AJ
      Combined acute disseminated encephalomyelitis and acute motor axonal neuropathy after vaccination for hepatitis A and infection with Campylobacter jejuni

      JOURNAL OF NEUROLOGY
    29. Kappos, L
      Multiple sclerosis trials

      LANCET
    30. Kappos, L; Moeri, D; Radue, EW; Schoetzau, A; Schweikert, K; Barkhof, F; Miller, D; Guttmann, CRG; Weiner, HL; Gasperini, C; Filippi, M
      Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis

      LANCET
    31. Zimmermann, C; Walther, EU; Goebels, N; Lienert, C; Kappos, L; Hartung, HP; Hohlfeld, R
      Interferon beta-1b for treatment of secondary progressive multiple sclerosis

      NERVENARZT
    32. Buttner, U; Chofflon, M; Hess, K; Kappos, L; Kesselring, J; Ludin, H; Rihs, F; Schluep, M; Vaney, C; Baumhackl, U; Berger, T; Freimuller, O; Hartung, HP; Kollegger, W; Kristoferitsch, W; Vass, K; Lassmann, H; Markut, S; Altenkirch, H; Boese, J; Gehlen, W; Goebels, N; Gold, R; Haas, J; Haferkamp, G; Heidenreic, F; Heitmann, R; Hohlfeld, R; Jugelt, E; Kolmel, H; Konig, N; Lowitzsch, K; Manegold, U; Mertin, J; Pette, M; Poser, S; Sailer, J; Schack, G; Schulz, M; Seidel, D; Stark, E; Stoll, G; Weinrich, W; Wietholter, H; Zettl, U; Zipp, F; Zschenderlein, R; Rieckmann, P; Toyka, KV; Chan, A; Bayas, A; Maurer, M; Jung, S; Gold, R; Weilbach, F; Cursiefen, S; Flachenecker, P; Rieckmann, P
      Escalating immunomodulatory therapy of multiple sclerosis

      NERVENARZT
    33. Plohmann, AM; Kappos, L
      A dubious therapy for patients with multiple sclerosis - Reply

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    34. Shamshiev, A; Donda, A; Carena, I; Mori, L; Kappos, L; De Libero, G
      Self glycolipids as T-cell autoantigens

      EUROPEAN JOURNAL OF IMMUNOLOGY
    35. LAMAN JD; THOMPSON EJ; KAPPOS L
      BODY-FLUID MARKERS TO MONITOR MULTIPLE-SCLEROSIS - THE ASSAYS AND THECHALLENGES

      Multiple sclerosis
    36. KAPPOS L; LEPPERT D; RADU EV
      TREATMENT - RELAPSING PHASE OF MULTIPLE-SCLEROSIS

      European journal of neurology
    37. LAMAN JD; THOMPSON EJ; KAPPOS L
      BALANCING THE TH1 TH2 CONCEPT IN MULTIPLE-SCLEROSIS/

      Immunology today
    38. KAPPOS L; POLMAN C; POZZILLI C; THOMPSON A; DAHLKE F; KNIGHT R; HERN J; COLEMAN R; GERRIE L; COOPER G; MOORE J; BORINGA J; VANOOSTEN B; RONNER H; SCHRIJVER H; TRUYEN L; MONTALBAN J; RIO J; TINTORE M; JACAS C; MARZO E; LECHNERSCOTT J; HUBER S; LIENERT C; BRUNNSCHWEILER H; HAWKINS S; DROOGAN A; MCDONNELL G; DUDDY M; MCKINSTRY S; ALTENKIRCH H; BAUM K; EINHAUPL K; MARX P; POEWE W; WALTER G; AKMAN H; BROCKMEIER B; SCHERER P; ZSCHENDERLEIN R; SCHMIERER K; GELDERBLOM H; HARTMANN A; STAPF C; LUSCHOW A; MACKERT B; SCHUMACHER H; MASUHR F; HEMPEL T; ZIMMERMANN R; MUNCH M; FRANCIS D; HEAFIELD M; ALMEMAR A; WINER J; CHONG M; BROCHET B; GAYOU A; AURIACOMBE S; DOUSSET V; WILES C; THOMAS F; PICKERSGILL T; HINDS N; DAWSON K; HUGHES T; HUTCHINSON M; MURPHY R; REDMOND J; WEBB S; STOLL G; JANDER S; HAGEMANN G; KOLLER H; HANEMANN C; KOLMEL H; REICHEL D; PETEREIT K; THIEME A; KHATAMI A; NEUMANN M; AMADUCCI L; MASSACESI L; SIRACUSA G; AMATO M; BARTOLOZZI L; REPICE A; MINDERHOUD J; DEKEYSER J; ZORGDRAGER A; ZWANIKKEN C; POSER S; POLAK T; GUNTHER A; BITSCH A; BORNER T; WEBER F; WIKSTROM J; FARKKILA M; MAJURI H; SUMELAHTI M; TELAKIVI T; FREDRIKSON S; MARTIN C; MILLER D; ORIORDAN J; BREX P; KAPOOR R; WERRING D; CONFAVREUX C; BRUNET P; HANNOUN D; BRUDON F; MOREAU T; BLANC S; DHOOGHE M; JACOBS K; LISSOIR F; DEMONTY L; COMI G; COLOMBO B; ROSSI P; RODEGHER M; SANTUCCIO G; MARTINELLI F; HOHLFELD R; WALTHER E; GOEBELS N; DANG T; LINDERT R; VOLTZ R; CARTLIDGE N; BATES D; MORAN G; PANDIT L; WESTWOOD M; HALLER P; SOMMER J; BITTER J; SUSS F; MELLIES J; MUCHA P; LYONCAEN O; DEGOS JD; ROULLET E; LUBETZKI C; CREANGE A; TOURBAH A; PEZ D; LECANUET P; NICOLT P; EDAN G; BELLIARD S; DEMARCO O; CAHAGNE V; DEBURGHGRAEVE V; BRUNET I; FIESCHI C; MILLEFIORINI E; GASPERINI C; BUTTINELLI C; FRONTINI M; HOWELL S; HADJIVASSILIOU M; GIBSON A; GRAHAM A; HARKNESS K; LAWDEN M; CLANET M; WAUBAN E; AZAISVUILLEMIN C; LAU G; LOUIS C; PANELIUS M; RUUTIAINEN J; ERALINNA J; SOILUHANNINEN M; GOLD R; HARTUNG HP; JUNG S; BAYAS A; FLACHENECKER P; WEILBACH F; ARCHELOS J; KOLLEGGER H; VASS K; ASENBAUM S; CHATSAKOS T; BECKMANN K; GHAZI M; WAGNER K; MILTENBURGER C; MCFARLAND H; PETKAU J; SABOURAUD O; TOYKA K
      PLACEBO-CONTROLLED MULTICENTER RANDOMIZED TRIAL OF INTERFERON BETA-1BIN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS

      Lancet
    39. EBERS GC; RICE G; LESAUX J; PATY D; OGER J; LI DKB; BEALL S; DEVONSHIRE V; HASHIMOTO S; HOOGE J; KASTRUKOFF L; KRIEGER C; MEZEI M; SELAND P; VOROBEYCHI G; MORRISON W; NELSON J; FREEDMAN MS; CHRISIE S; NELSON R; RABINOVITCH H; FREEDMAN C; HARTUNG HP; RIECKMANN P; ARCHELOS J; JUNG S; WEILBACH F; FLACHENECKE P; SAUER J; HOMMES O; JONGEN P; BROUWER S; MCLEOD J; POLLARD J; NG R; SANDBERGWOLLHEIM M; KALLEN K; NILSSON P; EKBERG R; LUNDGREN A; JADBACK G; WIKSTROM J; MULTANEN J; VALJAKKA M; CARTON H; LISSOIR F; DECLERQ I; VIEREN M; PEETERS E; DUBOIS B; DEKEERSMAEKER E; VANHERLE A; HUGHES RAC; SHARRACK B; SOUDAIN S; PANELIUS M; ERALINNA J; SOILUHANNINEN M; MURTO S; MEDAER R; BROECKX J; VANROOSE E; BOGAERS A; BLUMHARDT LD; EDWARDS S; LIU C; ORPE V; BARNES D; SCHWARTZ M; STOY N; HARRAGHY C; BERTELSMANN F; UITDEHAAG B; NASSERI K; CHOFFLON M; ROTH S; KAPPOS L; HUBER S; BELLAICHE Y; SENN C; KING J; JUBERT J; WHITTEN S; NEWSOMDAVIS JM; PALACE J; LEE M; EVANGELOU N; PINTO A; CAVEY A; SINDIC CJM; MONTEYNE P; VEROUGSTRAETE D; VANDOORN PA; MOLL W; VISSER L; WILLEMS M; MARTINA I; BULJEVAC D; LOMAN L; BATES D; PANDIT D; IRVING J; RHODES B; RIDDEHOUGH A; ZHAO GJ; WANG X; CHENG Y; AMMOURY N; DUPONT F; GALAZKA A; HYDE R; OLSON M; PERNIN MO; ABDULAHAD AK; HOMMES O; NOSEWORTHY J; BORDEN E; OBRIEN P; WOLINSKY J
      RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF INTERFERON BETA-1A IN RELAPSING REMITTING MULTIPLE-SCLEROSIS/

      Lancet
    40. PLOHMANN AM; KAPPOS L; AMMANN W; THORDAI A; WITTWER A; HUBER S; BELLAICHE Y; LECHNERSCOTT J
      COMPUTER-ASSISTED RETRAINING OF ATTENTIONAL IMPAIRMENTS IN PATIENTS WITH MULTIPLE-SCLEROSIS

      Journal of Neurology, Neurosurgery and Psychiatry
    41. Leppert, D; Ford, J; Stabler, G; Grygar, C; Lienert, C; Huber, S; Miller, KM; Hauser, SL; Kappos, L
      Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis

      BRAIN
    42. POEHLAU D; FEDERLEIN J; POSTERT T; SAILER M; BETHKE F; KAPPOS L; HAAS J; PRZUNTEK H
      INTRAVENOUS IMMUNOGLOBULIN (IVIG) TREATMENT FOR PATIENTS WITH PRIMARYOR SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS - OUTLINE OF A DOUBLE-BLIND RANDOMIZED, PLACEBO-CONTROLLED TRIAL

      Multiple sclerosis
    43. EBERS GC; OGER J; PATY D; LI D; FREEDMAN M; HARTUNG HP; HOMMES O; MCLEOD J; SANDBERG M; WIKSTROM J; CARTON H; HUGHES RAC; PANCELIUS M; MEDAER R; BLUMHARDT L; BARNES D; BERTELSMANN F; CHOFFLON M; KAPPOS L; KING J; NEWSOMDAVIS J; SINDIC C; UITEHAAG B; VANDOOM P; BATES D; DUPONT F; GALAZKA A; HYDE R; PERNIN MO; ABDULAHAD A
      THE MULTIPLE-SCLEROSIS PRISMS STUDY - PREVENTION OF RELAPSES AND DISABILITY BY INTERFERON BETA-1A SUBCUTANEOUSLY IN MULTIPLE-SCLEROSIS

      Annals of neurology
    44. BARKHOF F; FILIPPI M; MILLER DH; TOFTS P; KAPPOS L; THOMPSON AJ
      STRATEGIES FOR OPTIMIZING MRI TECHNIQUES AIMED AT MONITORING DISEASE-ACTIVITY IN MULTIPLE-SCLEROSIS TREATMENT TRIALS

      Journal of neurology
    45. VANWAESBERGHE JHTM; CASTELIJNS JA; ROSER W; SILVER N; YOUSRY T; NIJEHOLT GJLA; ADER HJ; UITDEHAAG BMJ; RADUE EW; POLMAN CH; KAPPOS L; MILLER DH; BARKHOF F
      SINGLE-DOSE GADOLINIUM WITH MAGNETIZATION-TRANSFER VERSUS TRIPLE-DOSEGADOLINIUM IN THE MR DETECTION OF MULTIPLE-SCLEROSIS LESIONS

      American journal of neuroradiology
    46. KAPPOS L; DOMMASCH D
      INTRACRANIAL ANEURYSMS

      The New England journal of medicine
    47. ROELCKE U; KAPPOS L; LECHNERSCOTT J; BRUNNSCHWEILER H; HUBER S; AMMANN W; PLOHMANN A; DELLAS S; MAGUIRE RP; MISSIMER J; RADU EW; STECK A; LEENDERS KL
      REDUCED GLUCOSE-METABOLISM IN THE FRONTAL-CORTEX AND BASAL GANGLIA OFMULTIPLE-SCLEROSIS PATIENTS WITH FATIGUE - A F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY STUDY

      Neurology
    48. LEPPERT D; HAUSER SL; KAPPOS L
      THE ROLE OF MATRIX METALLOPROTEINASES IN MULTIPLE-SCLEROSIS

      Journal of neurochemistry
    49. HURWITZ N; PROBST A; ZUFFEREY G; TICHELLI A; PLESS M; KAPPOS L; SPECK B; GRATWOHL A
      FATAL VASCULAR LEAK SYNDROME WITH EXTENSIVE HEMORRHAGE, PERIPHERAL NEUROPATHY AND REACTIVE ERYTHROPHAGOCYTOSIS - AN UNUSUAL COMPLICATION OFRECOMBINANT IL-3 THERAPY

      Leukemia & lymphoma
    50. HUBER S; SPYCHER M; LECHNERSCOTT J; BELLAICHE Y; STECK AJ; KAPPOS L
      MULTIPLE-SCLEROSIS - TREATMENT WITH RECOM BINANT INTERFERON BETA-1B

      Schweizerische medizinische Wochenschrift
    51. KAPPOS L; RADU EW; DELLAS S; HARTARD C; HARTUNG HP; HALLER P
      15+ --DEOXYSPERGUALINE (DSG) IN THE TREATMENT OF ACTIVE MULTIPLE-SCLEROSIS - FINAL ANALYSIS OF THE EUROPEAN MULTICENTER STUDY/

      Neurology
    52. GOLD R; BOGDAHN U; KAPPOS L; TOYKA KV; BAUMGARTNER ER; FOWLER B; WENDEL U
      HEREDITARY DEFECT OF COBALAMIN METABOLISM (HOMOCYSTINURIA AND METHYLMALONIC ACIDURIA) OF JUVENILE-ONSET

      Journal of Neurology, Neurosurgery and Psychiatry
    53. ROSER W; HAGBERG G; MADER I; BRUNNSCHWEILER H; RADUE EW; SEELIG J; KAPPOS L
      PROTON MRS OF GADOLINIUM-ENHANCING MS PLAQUES AND METABOLIC CHANGES IN NORMAL-APPEARING WHITE-MATTER

      Magnetic resonance in medicine
    54. KAPPOS L
      MULTIPLE-SCLEROSIS - DIAGNOSTIC PROCEDURE S AND NEW THERAPEUTIC DEVELOPMENTS

      Schweizerische medizinische Wochenschrift
    55. FILIPPI M; PATY DW; KAPPOS L; BARKHOF F; COMPSTON DAS; THOMPSON AJ; ZHAO GJ; WILES CM; MCDONALD WI; MILLER DH
      CORRELATIONS BETWEEN CHANGES IN DISABILITY AND T-2-WEIGHTED BRAIN MRIACTIVITY IN MULTIPLE-SCLEROSIS - A FOLLOW-UP-STUDY

      Neurology
    56. NICK S; PILERI P; TONGIANI S; UEMATSU Y; KAPPOS L; DELIBERO G
      CEREBROSPINAL-FLUID OF MULTIPLE-SCLEROSIS PATIENTS - MOLECULAR AND FUNCTIONAL ANALYSES OF T-CELL RECEPTOR-GAMMA-DELTA REPERTOIRE IS SKEWED IN ANTIGEN-REACTIVE GAMMA-DELTA CLONES

      European Journal of Immunology
    57. STECK AJ; KAPPOS L
      GANGLIOSIDES AND AUTOIMMUNE NEUROPATHIES - CLASSIFICATION AND CLINICAL ASPECTS OF AUTOIMMUNE NEUROPATHIES

      Journal of Neurology, Neurosurgery and Psychiatry
    58. TSAKIRIS DA; KAPPOS L; REBER G; MARBET GA; LEFLOCHROHR J; ROUX E; DEMOERLOOSE P
      LACK OF ASSOCIATION BETWEEN ANTIPHOSPHOLIPID ANTIBODIES AND MIGRAINE

      Thrombosis and haemostasis
    59. BARKHOF F; THOMPSON AJ; KAPPOS L; NAUTA JJP; YOUSRI T; BERRY I; SCOTTI G; APPEL B; TOFTS PS; MILLER DH
      DATABASE FOR SERIAL MAGNETIC-RESONANCE-IMAGING IN MULTIPLE-SCLEROSIS

      Neuroradiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/05/20 alle ore 02:47:51